Who owns LEXARIA BIOSCIENCE?
- Ticker: LEXX
- CUSIP Number: 52886n406
Tip: Access positions for across all investors
Analyze quarterly positions in Lexaria Bioscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lexaria Bioscience stock
Who bought or sold LEXARIA BIOSCIENCE this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Invenomic Capital Management | 732k | $915k | -4% | Dec 2023 |
|
| Cowen And Company | 256k | $320k | 100% | Dec 2023 |
|
| Vanguard Group | 46k | $58k | 39% | Dec 2023 |
|
| Raymond James Financial Services Advisors | 40k | $144k | 100% | Mar 2024 |
|
| Citadel Advisors | 30k | $37k | 100% | Dec 2023 |
|
| Welch Group | 24k | $87k | 100% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 10k | $38k | 100% | Mar 2024 |
|
| Oakworth Capital | 5.0k | $18k | 100% | Mar 2024 |
|
| UBS Group | 4.5k | $5.7k | 100% | Dec 2023 |
|
| ADAR1 Capital Management | 1.6k | $2.0k | 100% | Dec 2023 |
|
| Wells Fargo & Company | 1.1k | $1.3k | -2% | Dec 2023 |
|
| Jpmorgan Chase & Co | 1.0k | $1.3k | 100% | Dec 2023 |
|
| Advisor Group Holdings | 450.00 | $562.500000 | -31% | Dec 2023 |
|
| Aspire Private Capital | 400.00 | $1.5k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 394.00 | $0 | 0% | Dec 2023 |
|
| Farther Finance Advisors | 166.00 | $207.998000 | 0% | Dec 2023 |
|
| Hanson McClain Advisors | 89.00 | $323.995600 | 0% | Mar 2024 |
|
| Gables Capital Management | 13.00 | $16.000400 | 0% | Dec 2023 |
|
Who sold out of Lexaria Bioscience?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Securities | Sep 2023 | 11k | $11k |
| Sound Income Strategies | Dec 2023 | 22.00 | $27.999400 |